These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8603002)

  • 21. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
    Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
    Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
    Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
    J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group.
    Pelliniemi TT; Irjala K; Mattila K; Pulkki K; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Blood; 1995 Feb; 85(3):765-71. PubMed ID: 7530507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum oncostatin M in multiple myeloma: association with prognostic factors.
    Koskela K; Pelliniemi TT; Remes K; Rajamäki A; Pulkki K
    Br J Haematol; 1997 Jan; 96(1):158-60. PubMed ID: 9012701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
    Tamura T; Udagawa N; Takahashi N; Miyaura C; Tanaka S; Yamada Y; Koishihara Y; Ohsugi Y; Kumaki K; Taga T
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11924-8. PubMed ID: 8265649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Level of interleukin-6 (IL-6), soluble interleukin-6 receptors (sIL-6R) and tumor necrosis factor alpha (TNF-alpha) in untreated and progressing multiple myeloma].
    Usnarska-Zubkiewicz L
    Pol Arch Med Wewn; 1998 Jan; 99(1):30-7. PubMed ID: 9686501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of determining serum soluble IL-6 receptor concentration in plasma cell dyscrasias].
    Hou J; Zhao Y; Liu Y
    Zhonghua Nei Ke Za Zhi; 1997; 36(2):94-6. PubMed ID: 9812567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
    Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
    Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease.
    Hosokawa T; Kusugami K; Ina K; Ando T; Shinoda M; Imada A; Ohsuga M; Sakai T; Matsuura T; Ito K; Kaneshiro K
    J Gastroenterol Hepatol; 1999 Oct; 14(10):987-96. PubMed ID: 10530495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy.
    Gaillard JP; Bataille R; Brailly H; Zuber C; Yasukawa K; Attal M; Maruo N; Taga T; Kishimoto T; Klein B
    Eur J Immunol; 1993 Apr; 23(4):820-4. PubMed ID: 8458373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenström's macroglobulinemia.
    Hatzimichael EC; Christou L; Bai M; Kolios G; Kefala L; Bourantas KL
    Eur J Haematol; 2001 Jan; 66(1):1-6. PubMed ID: 11168500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
    Gaillard JP; Liautard J; Klein B; Brochier J
    Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
    Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
    Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study.
    Pulsatelli L; Boiardi L; Assirelli E; Pazzola G; Muratore F; Addimanda O; Dolzani P; Versari A; Casali M; Magnani L; Pignotti E; Pipitone N; Croci S; Meliconi R; Salvarani C
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):102-110. PubMed ID: 28466804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor.
    Hargreaves PG; Wang F; Antcliff J; Murphy G; Lawry J; Russell RG; Croucher PI
    Br J Haematol; 1998 Jun; 101(4):694-702. PubMed ID: 9674743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
    Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
    Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases.
    Yokoyama A; Kohno N; Hirasawa Y; Kondo K; Abe M; Inoue Y; Fujioka S; Fujino S; Ishida S; Hiwada K
    Clin Exp Immunol; 1995 May; 100(2):325-9. PubMed ID: 7743672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating interleukin-6 receptor in patients with sepsis syndrome.
    Frieling JT; van Deuren M; Wijdenes J; van der Meer JW; Clement C; van der Linden CJ; Sauerwein RW
    J Infect Dis; 1995 Feb; 171(2):469-72. PubMed ID: 7661926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.